Journey Medical Corp Director Justin Adam Smith's Restricted Stock Units Grant

On August 5, 2025, Justin Adam Smith, a director of Journey Medical Corp, was granted 20,000 restricted stock units (RSUs) under the company's 2015 Stock Plan, as amended. These RSUs will vest in three equal installments: 6,667 shares on August 5, 2028, 6,667 shares on August 5, 2029, and 6,666 shares on August 5, 2030. Following this transaction, Smith's total holdings in the company's common stock amount to 171,618 shares, which includes other restricted stock units that vest over various periods. The transaction was reported in a Form 4 filing with the SEC.